May 9, 2023 01:00PM Knight to Present at the 2023 RBC Capital Markets Global Healthcare Conference in New York City

May 11, 2022 09:30PM Knight to Present at the 2022 RBC Capital Markets Global Healthcare Conference in New York City

Nov 29, 2019 05:00PM Knight Therapeutics Announces Closing of Previously Announced Acquisition of Grupo Biotoscana

Oct 21, 2019 07:00AM Knight Therapeutics to Acquire Grupo Biotoscana, Establishing a Latin American Growth Platform

May 15, 2019 05:54PM Knight to Present at the 2019 RBC Capital Markets Global Healthcare Conference in New York City

May 7, 2019 08:21PM GUD Day for Knight: Shareholders Vote Overwhelmingly in Favour of Management

May 1, 2019 08:00AM As Deadline Approaches, Knight Therapeutics Reminds Shareholders to Vote the BLUE Proxy for Nominees Who Support Jonathan Goodman’s Vision

Apr 26, 2019 07:24PM Second Leading Proxy Advisor Rejects Meir Jakobsohn’s Attempt to Take Control of Knight Therapeutics’ Board

Apr 25, 2019 01:36PM Leading Independent Proxy Advisor, Key Shareholders, and More Analysts Back Jonathan Goodman’s Knight, Recommend Meir Jakobsohn Not be Re-elected to the Board

Apr 25, 2019 08:00AM Knight Therapeutics Releases New Letter to Shareholders, Reminds Shareholders of Important Vote

Apr 10, 2019 06:40PM Knight Receives Unanimous Support from Independent Analysts for Director Nominees, Current Strategy

Apr 8, 2019 07:00AM Knight Therapeutics Continues to Demonstrate Winning Strategy; Files Investor Presentation, Launches Microsite

Apr 4, 2019 08:45AM Knight Files Management Information Circular, Warns Shareholders of Activist Jakobsohn’s Self-Interested Agenda